Return to homepagePandemic Pact

OneDraw feasibility study launches - June 2020

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-499

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Prof. Nick Wareham

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Epidemiology Unit

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Social distancing measures and new ways of working mean that new methods of blood sample collection are urgently needed for Unit studies. In preparation for a large-scale surveillance study in the Fenland cohort to determine the prevalence of previous infection with COVID-19, a study has been launched to evaluate a self-applied blood collection using a device called OneDraw. It is important that we obtain adequate blood samples from participants using the dried blood spot (DBS) method that can be standardised as far as possible to undertake the COVID-19 serological testing repeatedly over a 6-month period.